| Outgoing Relation(s) |
| μ-opioid receptor antagonist (CHEBI:50137) is a opioid receptor antagonist (CHEBI:60605) |
| μ-opioid receptor antagonist (CHEBI:50137) is a μ-opioid agent (CHEBI:60599) |
| Incoming Relation(s) |
| levacetylmethadol (CHEBI:6441) has role μ-opioid receptor antagonist (CHEBI:50137) |
| nalbuphine (CHEBI:7454) has role μ-opioid receptor antagonist (CHEBI:50137) |
| naloxegol (CHEBI:82975) has role μ-opioid receptor antagonist (CHEBI:50137) |
| naloxone (CHEBI:7459) has role μ-opioid receptor antagonist (CHEBI:50137) |
| naloxone hydrochloride (CHEBI:31892) has role μ-opioid receptor antagonist (CHEBI:50137) |
| naltrexone (CHEBI:7465) has role μ-opioid receptor antagonist (CHEBI:50137) |
| naltrexone hydrochloride (CHEBI:134687) has role μ-opioid receptor antagonist (CHEBI:50137) |
| β-casomorphin-7 (human) (CHEBI:149635) has role μ-opioid receptor antagonist (CHEBI:50137) |
